Inventor · disambiguated record
David B. Belanger
Also filed as: BELANGER DAVID · BELANGER DAVID B
15 granted patents·9 pending applications·69 citations·filing 2000–2025
91Inventor score
Top patents by PatentIndex Score
24 records- 0187US7563798B2Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Jul 21, 2009·11 cites·3 claims
- 0286US7576085B2Imidazopyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2005·Granted Aug 18, 2009·10 cites·15 claims
- 0384US7511040B2Imidazopyrazines as protein kinase inhibitorsSCHERING CORP·Filed 2007·Granted Mar 31, 2009·8 cites·17 claims
- 0482US7652020B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 26, 2010·5 cites·48 claims
- 0579US8278337B2Substituted pyridines that are JNK inhibitorsBELANGER DAVID B·Filed 2007·Granted Oct 2, 2012·8 cites·25 claims
- 0675US6348496B115-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disordersALCON UNIVERSAL LTD·Filed 2001·Granted Feb 19, 2002·8 cites·9 claims
- 0771US6326499B1Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eyeALCON UNIVERSAL LTD·Filed 2000·Granted Dec 4, 2001·5 cites·4 claims
- 0871US6320062B115-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disordersALCON UNIVERSAL LTD·Filed 2000·Granted Nov 20, 2001·5 cites·3 claims
- 0969US6750250B111,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disordersALCON INC·Filed 2002·Granted Jun 15, 2004·1 cites·12 claims
- 1069US6255343B12,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of useALCON UNIVERSAL LTD·Filed 2000·Granted Jul 3, 2001·5 cites·12 claims
- 1167US6462061B1Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eyeALCON UNIVERSAL LTD·Filed 2001·Granted Oct 8, 2002·3 cites·17 claims
- 1264US2025120961A1P53 modulatorsNESTED THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1361US2025289811A1Heterocyclic derivatives as mitogen-activated protein kinase (mek) inhibitorsNESTED THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1451US7060728B211,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disordersALCON INC·Filed 2004·Granted Jun 13, 2006·0 cites·6 claims
- 1548US2010298314A1Novel jnk inhibitorsSCHERING CORP·Filed 2007·Application pending·0 cites
- 1645US2013116219A1Antimicrobial carboline compoundsALCON RES LTD·Filed 2012·Application pending·0 cites
- 1745US2007105864A1Methods for inhibiting protein kinasesSCHERING CORP·Filed 2006·Application pending·0 cites
- 1845US2007117804A1Imidazopyrazines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Application pending·0 cites
- 1944US2025288571A1Mitogen-activated protein kinase (mek) inhibitorsNESTED THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2041US2016145247A1Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereofBELANGER DAVID B·Filed 2014·Application pending·0 cites
- 2137US2008119515A1Heterocyclic Kinase Inhibitors: Methods of Use and SynthesisSIDDIQUI M ARSHAD·Filed 2004·Application pending·0 cites
- 2232US9765067B2Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted Sep 19, 2017·0 cites·19 claims
- 2331US9957254B2Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted May 1, 2018·0 cites·17 claims
- 2431US9227971B2Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsSIDDIQUI M ARSHAD·Filed 2011·Granted Jan 5, 2016·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when David B. Belanger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →